Sort
50,496 grants matching “lung cancer”
Cancer Risk in Human Populations
$1,126,839Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
Epigenomics of T cells and innate immune cells in human asthma
$1,126,630Anjana Rao · La Jolla Institute For Immunology · R01 · FY2011 · HL
Incorporating residential histories into assessment of cancer risk
$1,126,520Melinda Aldrich · Vanderbilt University Medical Center · R01 · FY2025 · CA
Center of Excellence in Environmental Toxicology
$1,125,969Trevor M. Penning · University Of Pennsylvania · P30 · FY2021 · ES
Novel bi-specific immunotherapeutic against high-threat Gram-negative pathogens
$1,125,966David S Perlin · Hackensack University Medical Center · R01 · FY2021 · AI
Cancer in Your Community: Strategies to Reduce Cancer and Chronic Disease in the Arkansas Delta
$1,124,585Trena Mitchell · Arkansas Cancer Coalition · OT2 · FY2023 · OD
Improving lung cancer surgery with an intraoperative, tumor-targeted, activatable fluorescent imaging agent
$1,124,282Eric Scott Bensen · Vergent Bioscience, Inc. · R44 · FY2022 · CA
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
$1,124,257Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
NOX family NADPH oxidases: roles in innate immunity and inflammatory disease
$1,123,750Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Cancer Risk in Human Populations
$1,123,133Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)
$1,122,959Rachel Caskey · University Of Illinois At Chicago · UH3 · FY2024 · HL
Data Processing, Analysis, and Modeling Unit
$1,122,731Marc Elliott Lenburg · Boston University Medical Campus · U2C · FY2018 · CA
Fluorescence Microscopy
$1,122,518Charles Tucker · National Institute Of Environmental Health Sciences · ZIC · FY2019 · ES
Molecular Pathology of Pulmonary Carcinogenesis
$1,122,103Ilona Linnoila · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)
$1,121,152Patricia Ann Thompson-Carino · University Of Arizona · UG1 · FY2024 · CA
Modulation of Therapeutic Response
$1,121,091James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC): TASK AREA A AND A2
$1,121,018Marcia Stefanick · Stanford University · N01 · FY2025 · HL
ROLE OF THE FHIT LOCUS IN ENVIRONMENTAL CARCINOGENESIS
$1,120,885Thomas Jefferson University · P01 · FY2002 · CA
Emergency Myelopoiesis in the Control of Blood Production
$1,120,635Emmanuelle Passegue · Columbia University Health Sciences · R35 · FY2025 · HL
PET Enabled Y-90 Microspheres for Radioembolization of Liver Tumors
$1,120,462Yongren Benjamin Peng · Xl Sci-Tech, Inc. · R44 · FY2021 · CA
Transgenic Models for Prostate and Breast Cancer
$1,120,018Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
East Coast AIDS and Cancer Specimen Bank
$1,119,815Sylvia Silver · George Washington University · U01 · FY2007 · CA
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)
$1,119,544H-H. Sherry Chow · University Of Arizona · UG1 · FY2022 · CA
BAY AREA & ANDERSON TEAM AGAINST ACQUIRED RESISTANCE - U54 PROGRAM (BAATAAR-UP)
$1,119,180Trever G Bivona · University Of California, San Francisco · U54 · FY2022 · CA
Ann Arbor regional CCOP
$1,118,919Saint Joseph Mercy Health System · U10 · FY2004 · CA